Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India

High antibiotic and antifungal concentrations in wastewater from anti-infective drug production may exert selection pressure for multidrug-resistant (MDR) pathogens. This study investigated the environmental presence of active pharmaceutical ingredients and their association with MDR bacteria in Hyderabad, South India, a major production area for the global bulk drug market.
Water samples were collected from the direct environment of bulk drug manufacturing facilities. Samples were analyzed for 25 anti-infective pharmaceuticals.   All environmental specimens from 28 different sampling   sites   were   contaminated   with   antimicrobials.

High  concentrations  of  moxifloxacin,  voriconazole,  and fluconazole  as  well  as  increased  concentrations  of  eight  other antibiotics  were  found  in  sewers.  Corresponding analyses  revealed  an  extensive  presence  of  enterobacteria.   Insufficient  wastewater  management  by  bulk   drug  manufacturing  facilities  leads  to  unprecedented  contamination  of  water  resources  with  antimicrobial  pharmaceuticals,  which  seems  to  be  associated  with  the  selection  and dissemination of pathogens.  The development and global spread of antimicrobial resistance present a major challenge for pharmaceutical producers and regulatory agencies.

Citation: Lübbert, C., Baars, C., Dayakar, A. et al. Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens Infection (2017). Published online on April 26,2017.

How the NAFTA Diet Made Mexico Sick

Credit

During the campaign, President Donald Trump threatened to withdraw from NAFTA, calling it “a disaster since the day it was devised,” write Alyshia Galvez and Nicholas Freudenberg in an op ed in the Dallas Morning News. But last week, he said he will “bring NAFTA up to date through renegotiation.”  However, neither Trump nor those on either side of the trade wars has given any hint that they know about one of NAFTA’s most distressing consequences: its adverse impact on the health of the Mexican people.  For those who believe that fair trade agreements can benefit all, the goal should be a renegotiated NAFTA that puts the well-being of all North Americans first. A trade agreement that favors sustainable agriculture, labor mobility and a food system oriented toward health — not corporate profits — would be good for us all.

Illinois Senate passes gun dealer licensing bill, moves to Illinois House

The Illinois Senate passed a gun dealer licensing bill, known as Senate Bill 1657, in a 30-21 vote, according to Democratic Senator Don Harmon’s press office, reports WABC 7 Eyewitness News in  Chicago. “This was a difficult and a controversial bill, I know,” Harmon said in a press release. “I appreciate the support of every senator who was able to put children and families ahead of the NRA.” According to the release, the bill would allow Illinois to license gun dealers and encourage better business practices while holding corrupt dealers accountable.

America’s second-largest school district says no to McDonald’s McTeachers’ Nights

In a victory for public health, reports Salon, the board of the Los Angeles Unified School District, the second-largest school district in the country, adopted a resolution to end McDonald’s McTeacher’s Nights. The resolution comes as millions of parents, educators and health professionals call on junk food corporations to stop kid-targeted marketing. To date, United Teachers Los Angeles, the National Education Association and more than 50 state and local teachers unions, representing more than 3 million educators nationwide, have demanded junk food corporations stop marketing to children in schools. McTeacher’s Nights are events at which McDonald’s invites teachers to “work” behind a McDonald’s counter and serve McDonald’s burgers, fries, and soda to students, students’ families, and other people eating at the restaurant. McDonald’s, in return, donates a small percentage of the night’s proceeds to the school — often amounting to only $1-2 per student.

A Citizen’s Pathway Gone Astray –Delaying Competition from Generic Drugs

Screen Shot 2017-04-27 at 4.51.03 PM

Credit

In a commentary in the New England Journal of Medicine, Robin Feldman and Connie Wang write that pharmaceutical companies have become adept at converting regulatory pathways into vehicles for profit-boosting strategies.  They study the “citizen-petition process” that the Food and Drug Administration implemented in the 1970s to give the average citizen a way to voice concerns.  Using 12 years of FDA data, they found that the “concerned citizen” is frequently a drug company raising frivolous or questionable claims in a last-ditch effort to hold off competition.

New Danone Public Benefit Corporation: Wave of the Future for Corporate America?

The tie up between Danone’s North American dairy business and WhiteWave has created one of the top-15 U.S. food and beverages companies by sales, as well the country’s no. 1 dairy business (excluding cheese), reports Fortune.  But the new unit, called DanoneWave, now tops another ranking and one that has nothing to do with food: On April 12, the day the acquisition of WhiteWave was approved, the newly formed enterprise received its status of “public benefit corporation”—the largest company in the U.S. to have that distinction. A benefit corporation has a certain legal framework that is meant to hold a company to a higher standard than the pure pursuit of profit. Instead, it’s mandated to balance the interests of all stakeholders, rather than prioritize shareholders, and is required to create a positive impact on society.

Big tax cuts for the rich leave less for the poor

A group of conservative think tanks wants the nation’s tax system to look more like North Carolina’s, writes the Center for Public Integrity.  In Washington, D.C., the Trump administration and Congressional Republicans have been considering a similar approach — lower federal income-tax brackets and a tax on imports — that some tax experts say would have comparable outcomes. Some of the same conservative groups that convinced states to change their tax systems have advised the Trump administration on economic and tax policy.  But so far, for the working poor, that hasn’t been a great deal. While Congress prepares for the tax debate, single-parents in Asheville worry that the proposed federal tax changes would only make life harder, as North Carolina’s tax reforms did. “They’re going to come for every little penny that you have,” said one. “Where is the help when we need it?”

Countermarketing Unhealthy Food: An Effective Strategy for Preventing Noncommunicable Diseases? Lessons from Tobacco

Image from Youth Food Educators of East Harlem

Countermarketing campaigns use health communications to reduce the demand for unhealthy products by exposing motives and undermining marketing practices of producers. These campaigns can contribute to the prevention of noncommunicable diseases by denormalizing the marketing of tobacco, alcohol, and unhealthy food. By portraying these activities as outside the boundaries of civilized corporate behavior, countermarketing can reduce the demand for unhealthy products and lead to changes in industry marketing practices. Countermarketing blends consumer protection, media advocacy, and health education with the demand for corporate accountability. Countermarketing campaigns have been demonstrated to be an effective component of comprehensive tobacco control. This review describes common elements of tobacco countermarketing such as describing adverse health consequences, appealing to negative emotions, highlighting industry manipulation of consumers, and engaging users in the design or implementation of campaigns. It then assesses the potential for using these elements to reduce consumption of alcohol and unhealthy foods.

Full citation: Palmedo PC, Dorfman L, Garza S, Murphy E, Freudenberg N. Countermarketing Alcohol and Unhealthy Food: An Effective Strategy for Preventing Noncommunicable Diseases? Lessons from Tobacco. Annu Rev Public Health. 2017;38:119-144.

New York City Is Oversaturated with Licensed Tobacco Retail Outlets

For more than a decade New York City has led a historic and successful effort to reduce smoking, driving down smoking rates to historic lows. Despite these efforts, about 950,000 people still smoke and significant disparities persist by education, household income and mental health.  One reason why tobacco use is still the number one cause of preventable disease and death in New York City is the overwhelming number of places where tobacco can be legally purchased in the five boroughs.  In a new report, the American Cancer Society Cancer Actions Network recommends that New York City should:

• Establish a cap on retail tobacco licenses

• Restrict access near youth-service entities

• Restrict retail outlet proximity to each other

• Restrict all tobacco sales in pharmacies

• Add restrictions on other tobacco products

Questions for Trump’s FDA Nominee

Credit

The Food and Drug Administration’s approach to consumer protection faces a potential turning point when a Senate committee takes up President Trump’s nomination of Scott Gottlieb to head the agency, writes POGO, the nonprofit  Project on Government Oversight.  Trump has called for slashing FDA restraints on pharmaceuticals, and with Gottlieb’s appointment he would entrust the task to a doctor and former FDA official who has been immersed in the pharmaceutical industry. One of The FDA’s main missions is making sure that prescription medicines sold to the public are safe and effective. The FDA gets much of its funding through so-called “user fees” paid by pharmaceutical and medical device companies, and the money comes with strings attached, giving industry extraordinary leverage over its federal overseer. In Gottlieb, Trump  has chosen a potential FDA commissioner whose financial disclosures list line after line of payments from drug and biotech companies.